<DOC>
	<DOCNO>NCT00044460</DOCNO>
	<brief_summary>The purpose study gain safety efficacy information patient type 2 diabetes , previously take oral antidiabetic medication , HbA1c value great equal 10 % , despite diet exercise .</brief_summary>
	<brief_title>Efficacy Safety In Poorly Controlled Type 2 Diabetics</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Rosiglitazone</mesh_term>
	<criteria>Inclusion criterion : Type 2 diabetes Drugnaive . Laboratory test result HbA1c great equal 10 % . Written informed consent . Exclusion criterion : Prior use antidiabetic medication within 3 month screen . Fluid retention ( edema ) . Significant liver disease . Low red blood cell ( anemia ) . Severe unstable angina ( chest pain ) . Congestive heart failure . Severe high blood pressure . Alcohol drug abuse . Other inclusion exclusion criterion determine physician study sponsor .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Type 2 diabetes drug-naive</keyword>
</DOC>